Leprosy Susceptibility To 5 C2750733
Inherited genetic factor potentially associated with increased likelihood of developing leprosy, a treatable infection of skin and nerves.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Painless skin ulcers
(integumentary)Peripheral sensory loss
(neurologic)Joint contractures due to nerve involvement
(musculoskeletal)Systemic immunologic manifestations such as fever
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Regular epidemiological surveillance
Periodic health assessments in endemic regions with skin examinations and nerve function tests to enable early detection of leprosy if infection occurs.
Immune system optimization
Maintaining robust general health through adequate sleep, stress management, and regular exercise to support innate immunity against mycobacterial infections.
Additional treatment options
Nutritional support with vitamin D
Ensuring adequate intake of vitamin D, zinc, and protein through diet or supplementation to support cellular immunity and macrophage function.
dietarySunlight exposure therapy
Moderate ultraviolet exposure to promote vitamin D synthesis, which plays a role in modulating immune responses to mycobacteria.
complementaryProphylactic immunomodulation assessment
Evaluation by infectious disease specialist for potential immunomodulatory interventions in high-exposure scenarios.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Leprosy Susceptibility To 5 C2750733?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
WHO Expert Committee on Leprosy. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. WHO Technical Report Series. 2022.
Sauer ME, Santos HP, Oliveira EB. Genetic Susceptibility to Leprosy: A Systematic Review of Candidate Gene Studies. Int J Lepr Other Mycobact Dis. 2021.
Moraes MN, Silva JR, Chen L, et al. Association of HLA Variants with Leprosy Susceptibility in a Brazilian Cohort: A Case-Control Study. PLoS Negl Trop Dis. 2020.
Zhang H, Liu Q, Wang Y, Fernandez-Ruiz J. PARS2 and PARK2 Gene Polymorphisms and Leprosy Susceptibility: A Meta-Analysis of 12 Studies. J Dermatol. 2023.
Medication Comparisons
Compare medications used to treat Leprosy Susceptibility To 5 C2750733. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy